Fact CheckerSign in

NCT06967584Completed

Kinesiotaping on HP Patients Pulmonary Parameters

Effects of Thoracic Kinesio Taping on Pulmonary Functions, Respiratory Muscle Strength and Functional Capacity in Patients With Hemiplegia

Source: ClinicalTrials.gov · Last updated 25 Jul 2025

Brief summary (registry, in English)

The aim of this study is to investigate whether thoracic kinesio taping contributes to the improvement of pulmonary function, the strengthening of respiratory muscles and the enhancement of overall physical ability in stroke patients with hemiplegia. To assess this, a randomized controlled trial will be conducted involving 30 patients aged between 45 and 80 years who have been diagnosed with hemiplegia resulting from a stroke. Participants will be randomly assigned to one of two groups: the Kinesio Taping Group (KTG) or the Sham Kinesio Taping Group (SKTG). The duration of the intervention will be four weeks. During this period, individuals in the KTG will receive thoracic kinesio taping in addition to standard rehabilitation care. In the SKTG, taping will be applied to the same thoracic area but without tension. Measurements will be obtained both before and after the intervention. These assessments will include pulmonary function tests (such as forced vital capacity and forced expiratory volume), evaluations of respiratory muscle strength (specifically maximum inspiratory pressure), and assessments of functional capacity.

Status (registry)
Completed
Study type
Interventional
Enrollment
30 (actual)
First submitted
19 Apr 2025
Start date
11 Nov 2024
Primary completion date
23 Jul 2025
Lead sponsor
Istinye University
Diseases
Stroke
NCT number
NCT06967584

What you commit to

  • Study type: Interventional
  • Participants enrolled: 30
  • From 11 Nov 2024 to the primary completion date, 23 Jul 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Severe heart diseases like heart failure, unstable hypertension, previous angina pectoris or myocardial infarction

Other illness

  • Any Other neurological or orthopedic problems that will affect function other than Stroke
  • Mental and cognitive disorders that would affect cooperation.

Other

  • Patients having unstable
  • Skin sensitivity against kinesio tape
  • Lesion or incision in the area of kinesio tape application
  • Use of analgesics during study period .

Who the study is looking for

  • The patients with stroke diagnosis by a neurologist
  • 45-80 years old
  • Participating to the study in a voluntary basis.
  • Patients with clinical setting
  • Patient diagnosed at lest stroke attack within 6 months
  • They are Medically stable situation

Age in the registry: 45 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Istinye University Bahcesehir Liv Hospital
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.